Prothena plc Stock Price Patterns
| PRTA Stock | USD 8.59 -0.41 -4.56% |
Momentum
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter -0.32 | EPS Estimate Current Year 0.64 | EPS Estimate Next Year -1.04 | Wall Street Target Price 21 | EPS Estimate Current Quarter -0.46 |
This view aligns Prothena Plc's headline activity with price response and peer context. This module summarizes sentiment around Prothena Plc using options and short interest metrics.
Short Interest Panel - Prothena Plc
Changes in Prothena Plc's short interest are tracked as sentiment context. The series is informational and can be read with price and volatility context.
200 Day MA 8.6523 | Short Percent 0.1519 | Short Ratio 16.53 | Shares Short Prior Month 7.1 M | 50 Day MA 9.1766 |
Prothena plc Hype vs Price Pattern
Average sentiment around Prothena Plc is summarized to provide attention context. The panel summarizes sentiment trends as informational context.
Correlation between sentiment and price for Prothena Plc can be reviewed as contextual information. The output is informational and does not imply direction.
Prothena Plc Implied Volatility | 1.28 |
Implied volatility for Prothena Plc provides a market-based measure of expected variability. Higher values indicate wider expected ranges, while lower values indicate tighter ranges.
The attention view for Prothena Plc connects headline intensity with short-term volatility context.
Prothena Plc after-hype prediction price | $ 8.59 |
This module presents attention signals alongside forecasting, technical analysis, analyst consensus, and earnings.
Rule 16 Reference for the current Prothena contract
Rule 16 converts implied volatility into an estimated daily move of about 0.08% for 2026-06-18 options. With Prothena Plc trading near $ 8.59, that translates to about $ 0.01 per day in either direction.
Prothena | Build portfolio with Prothena Stock |
The degree to which Prothena Plc's exhibits mean reversion depends on how efficiently the market prices new information. In highly covered equities, the mean reversion window tends to be shorter.
After-Hype Price Density Analysis
The after-hype price distribution for Prothena Plc helps investors understand how much of Prothena Plc's predicted return comes from the central scenario versus tail outcomes. Strategies that rely on tail events for Prothena Plc are inherently more speculative.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
Historical news patterns for Prothena Plc reveal how the market has historically digested different types of information about Prothena Plc's business and market environment. Prothena Plc's after-hype downside and upside margins for the prediction period are 5.75 and 11.43, respectively. The model extrapolates these patterns to estimate likely price boundaries following the next significant.
Current Value
Macroaxis estimates the after-hype price of Prothena plc across a 3 months horizon to evaluate where the instrument could settle once headline distortion subsides. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Prothena Plc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Prothena Plc backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Prothena Plc, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.08 | 2.86 | 0.00 | 0.01 | 9 Events | 7 Events | In 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
8.59 | 8.59 | 0.00 |
|
Hype Timeline
Prothena plc is at this time traded for 8.59. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Prothena is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at -0.08%. %. The volatility of related hype on Prothena Plc is about 3575.0%, with the expected price after the next announcement by competition of 8.60. About 19.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.73. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Prothena plc has Price/Earnings To Growth (PEG) ratio of 0.8. The company recorded a loss per share of 4.53. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in 9 days. Prothena Plc Basic Forecasting Models can be used to cross-verify projections for Prothena Plc. The models provide an additional statistical reference.Related Hype Analysis
Peer hype analysis helps investors build a more complete picture of Prothena Plc's competitive environment by quantifying the market's sensitivity to news across all major players in Prothena Plc's sector.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KALV | Kalvista Pharmaceuticals | -0.26 | 8 per month | 0.00 | 0.0011 | 4.87 | -6.60 | 15.04 | |
| BCYC | Bicycle Therapeutics | -0.02 | 9 per month | 0.00 | -0.17 | 4.64 | -6.93 | 12.21 | |
| FDMT | 4D Molecular Therapeutics | -0.03 | 4 per month | 0.00 | -0.03 | 7.15 | -9.32 | 25.26 | |
| VSTM | Verastem | -0.03 | 14 per month | 0.00 | -0.16 | 5.85 | -7.51 | 19.78 | |
| OLMA | Olema Pharmaceuticals | 0.51 | 11 per month | 0.00 | -0.18 | 8.11 | -7.31 | 35.57 | |
| VTYX | Ventyx Biosciences | -0.03 | 7 per month | 2.74 | 0.13 | 9.00 | -6.33 | 37.04 | |
| NMRA | Neumora Therapeutics | -0.07 | 8 per month | 3.71 | 0.1 | 10.98 | -7.10 | 34.13 | |
| CRVS | Corvus Pharmaceuticals | 0.74 | 7 per month | 3.80 | 0.1 | 7.35 | -8.33 | 175.94 | |
| GOSS | Gossamer Bio | -0.02 | 11 per month | 0.00 | -0.15 | 9.30 | -9.52 | 89.87 | |
| RIGL | Rigel Pharmaceuticals | 0.01 | 15 per month | 0.00 | -0.20 | 4.17 | -5.37 | 18.93 |
Prothena Plc Additional Predictive Modules
Predictive models for Prothena Plc combine technical indicators with statistical methods to estimate probable price trajectories. Time-series models tend to perform better when fed clean, stationary data with consistent periodicity.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for Prothena Plc evaluates news tone, positioning, and narrative momentum. Narrative divergence can signal instability and regime transition risk. Prothena Plc has a market cap of 462.43 M, P/E of 37.12, ROE of -63.62%.
Unless otherwise specified, data for Prothena plc is compiled from periodic company reporting and market reference feeds and standardized for comparability. Analyst projections are included when active coverage applies. Updates may occur throughout the day.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Popular Tools for Prothena Stock analysis
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |